WEST LAFAYETTE, IND. (PRWEB) JULY 20, 2020 Improved Pharma is pleased to announce new collaborations with Westport Pharmaceutical Consulting, LLC (dba WPC, LLC) and Ravine Pharmaceuticals LLC enabling expansion of expertise and service offerings to the pharmaceutical industry in support of drug substance and drug product development. These additions bring a vast amount of relevant industrial Read more
Polymorph screens and salt screens are important components for drug development. The goal of polymorph screening is to try to find all possible crystal forms by small-scale crystallization and to select a stable form that can be manufactured and formulated into a dosage form. Salt screens are commonly used to alter the physicochemical properties of Read more
Accelerated development is a complex and difficult task. S-fIND (Synchrotron-based fast to IND) is a strategy to speed development of the most difficult cases using powerful X-ray methods only available at a Synchrotron X-ray source. S-fIND integrates powerful methods with practical pharmaceutical development approaches and excellent people in a package that accelerates development. Accelerated development services Read more
WEST LAFAYETTE, IND. (PRWEB) JUNE 02, 2020 In response to growing demands for services, Improved Pharma, LLC is pleased to announce a collaboration with Dr. Dale K. Purcell of Chemical Microscopy, LLC to provide services related to microscopy and microspectroscopy to Improved Pharma clients. With this collaboration comes the acquisition of HORIBA’s Xplora Series Raman Microscope. Raman mapping is a powerful Read more
Not according to the United States Court of Appeals, citing Improved Pharma’s CSO Steve Byrn’s early paper on polymorph screening. The United States Court of Appeals for the Federal Circuit is known as the Supreme Court of patents, and its rulings are typically considered as significant landmarks in the patent and innovation field. In a Read more
WEST LAFAYETTE, IN (PRWEB) MAY 06, 2020 Improved Pharma has added new capabilities to their existing microscopy services. Now in addition to stereomicroscopy and polarized light microscopy, Improved Pharma can provide analysis via infrared microspectroscopy and hot stage optical microscopy. Improved Pharma has expanded their in-house microscopy services. In addition to stereomicroscopy and polarized light Read more
A recent paper by Testa et al., Int. J. Pharm., 556 (2019) 125, investigated the mixture analysis of Olanzapine, which crystallizes in more than 60 solid forms, using synchrotron X-ray diffraction. They suggested that synchrotron techniques could help guide the discovery of methods to prepare and analyze pure polymorphs. Their observations and suggestions are consistent Read more
WEST LAFAYETTE, IND. (PRWEB) MARCH 05, 2020 Improved Pharma has moved into new laboratory space in the Purdue Research Park of West Lafayette IN. The new facilities are located in the Kurz Purdue Technology Center, home of the Purdue Railyard which is one of the country’s largest co-working facilities for innovators and entrepreneurs. In addition to dedicated laboratory Read more
Laboratory powder diffraction is a proven and trusted technique for pharma R&D, but synchrotron powder diffraction pushes beyond the capabilities of conventional instrumentation. SPS-XRPD-3 will highlight the most exciting recent developments and opportunities in pharmaceutical R&D made possible by synchrotron XRPD. The meeting offers the chance to engage an active network of synchrotron, academic Read more
WEST LAFAYETTE, IND. (PRWEB) DECEMBER 26, 2019 2019 was another great year for Improved Pharma LLC, highlighted by a highly successful AAPS meeting and several internal advances in our problem-solving capabilities. At the AAPS, the Improved Pharma booth was grouped with other formulation companies and was able to establish several contacts and initial collaborations. Improved Pharma was Read more
